Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Fibrobiologics Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
CF
Cascade Financial Partners, LLC
|
108.8K | 1.63% | +92.4K (+562.5%) | 2024 | 0.0% | |
|
Shares held by quarter
Peak holding314.6K (Q4'25)
Change over 8 quarters−193.8K
Share of the company1.630%
|
||||||
|
VC
Vanguard Capital Management LLC
|
27.8K | 0.42% | −39.9K (−59.0%) | 2024 | 0.0% | |
|
Shares held by quarter
Peak holding67.7K (Q1'26)
Change over 8 quarters+27.8K
Share of the company0.420%
|
||||||
18 more super investors behind a free account
See every manager holding Fibrobiologics Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$52.7K | 39.9K | 0.60% | 0.00% | March 31, 2026 |
|
FE
Fidelity Concord Street Trust
|
$41.7K | 24.2K | 0.36% | 0.00% | August 31, 2026 |
7 more funds behind a free account
See every fund holding Fibrobiologics Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
HK
Hamid Khoja
5%+ holder
13D · 7.5%
|
630.0K | 9.46% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
OP
O'Heeron Pete
Insider
|
22.9K | 0.34% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company0.340%
|
||||||
2 more holders behind a free account
See every insider and 5%+ holder of Fibrobiologics Inc.
Sign up freeLoading...